Stephen Doster
-
Dr. James Crowe Jr. receives SEC Faculty Achievement Award
by Ann Marie Deer Owens Apr. 8, 2021, 1:30 PM Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. (John Russell/Vanderbilt University) Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research… Read MoreApr. 9, 2021
-
Study revises understanding of cancer metabolism
Apr. 7, 2021, 10:00 AM From left, Kimryn Rathmell, MD, PhD, Bradley Reinfeld, Matthew Madden and Jeffrey Rathmell, PhD, have discovered that immune cells — not cancer cells — are the major glucose consumers in the tumor microenvironment, upending a century-old observation. (photo by Susan Urmy) by Leigh MacMillan Tumors… Read MoreApr. 9, 2021
-
Mark Denison Receives Joe B. Wyatt Distinguished University Professor Award
The Joe B. Wyatt Distinguished University Professor Award, established in honor of Chancellor Joe B. Wyatt upon his retirement in 2000, recognizes faculty accomplishments that span multiple academic disciplines. Denison, Edward Claiborne Stahlman Professor of Pediatric Physiology and Cell Metabolism and one of the world’s foremost experts on coronaviruses,… Read MoreApr. 2, 2021
-
Novel way to neutralize Rift Valley Fever Virus
Apr. 1, 2021, 11:00 AM by Bill Snyder Rift Valley Fever Virus (RVFV) is an emerging infection in sub-Saharan and North Africa that causes severe, hemorrhagic illness in livestock and humans and which has pandemic potential. James Crowe Jr., MD, and colleagues isolated a panel of human monoclonal antibodies from… Read MoreApr. 2, 2021
-
Breast cancer cells ‘steal’ nutrients from immune cells: study
Apr. 1, 2021, 9:33 AM Deanna Edwards, PhD, left, Jin Chen, MD, PhD, and colleagues are studying a new therapeutic strategy for triple-negative breast cancer. (photo by Donn Jones) by Leigh MacMillan Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and… Read MoreApr. 2, 2021
-
Study shows new COVID target could improve vaccines
Apr. 1, 2021, 9:23 AM by Bill Snyder Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus. Current vaccines and… Read MoreApr. 2, 2021
-
Identifying a novel treatment for heart attacks
Professor David Merryman explains how his team targeted the serotonin 2B receptor in animal models to preserve cardiac function six weeks after a heart attack. Researchers at Vanderbilt University in the US report that they have identified a protein receptor in specialised heart cells that, when removed, preserves cardiac function… Read MoreMar. 26, 2021
-
Vanderbilt expert to speak about how the COVID-19 pandemic has affected addiction on March 26
by Marissa Shapiro Mar. 22, 2021, 3:45 PM Addiction expert and Assistant Professor of Pharmacology Erin Calipari will speak at the 17th annual fundraising breakfast for Mending Hearts about how the COVID-19 pandemic has affected people suffering from addiction. Erin Calipari… Read MoreMar. 26, 2021
-
Vanderbilt experts discuss colorectal cancer research progress in virtual event
by Marissa Shapiro Mar. 22, 2021, 9:00 AM In recognition of Colorectal Cancer Awareness Month, the School of Medicine Basic Sciences will host a panel discussion, “On the Cutting Edge: Research Toward a Cure for Colorectal Cancer,” on Tuesday, March 30, from 11… Read MoreMar. 25, 2021
-
Vanderbilt Institute of Chemical Biology’s 500th seminar to feature acclaimed biochemist and inventor Michael Marletta
by Marissa Shapiro Mar. 17, 2021, 9:00 AM By Miquéla Thornton Award-winning biochemist, inventor and educator Michael Marletta will speak about his nearly 50 years of studying nitric oxide—the body’s first line of defense against infection—during a seminar presented by the Vanderbilt… Read MoreMar. 22, 2021